Mitchell R Smith
Overview
Explore the profile of Mitchell R Smith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
5118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smith M, Azoulay M, Greenberger L
Clin Lymphoma Myeloma Leuk
. 2025 Feb;
PMID: 39971667
No abstract available.
2.
Choudhary G, Tat T, Misra S, Hill B, Smith M, Almasan A, et al.
Oncotarget
. 2024 Jul;
15:468-469.
PMID: 39007277
No abstract available.
3.
OBrien-Smith J, Smith M, Lenoir M, Fransen J
Res Q Exerc Sport
. 2024 Jun;
96(1):109-115.
PMID: 38941626
: The relationship between task constraints and player behaviors is of interest to coaches tasked with designing practice to optimize learning. This study aims to compare the skill involvements and...
4.
Smith M, Jegede O, Martin P, Till B, Parekh S, Yang D, et al.
Blood
. 2024 May;
144(10):1083-1092.
PMID: 38820500
Although initial therapy of mantle cell lymphoma (MCL) is not standardized, bendamustine plus rituximab (BR) is commonly used in older patients. Rituximab (R) maintenance after induction is often used. Thus,...
5.
OBrien-Smith J, Smith M, Vansteenkiste P, Fransen J, Zeuwts L, Bennett K, et al.
Sci Med Footb
. 2024 Mar;
:1-9.
PMID: 38512014
This study aimed to explore the perceptual-cognitive characteristics of coaches as they assessed team performance in youth soccer. The primary focus was to investigate the alignment between coaches' subjective analyses...
6.
Hill B, Chen Y, Jagadeesh D, Dean R, Koc O, Boughan K, et al.
Leuk Lymphoma
. 2024 Mar;
65(6):768-773.
PMID: 38456694
Lenalidomide and rituximab (R) is an effective frontline treatment for patients with indolent B-cell non-Hodgkin lymphoma (iNHL). We investigated the safety and efficacy of addition of the proteasome inhibitor ixazomib...
7.
Luttwak E, Smith M, Zelenetz A
Expert Opin Pharmacother
. 2023 Jun;
24(12):1331-1334.
PMID: 37294016
No abstract available.
8.
Le K, Sun J, Ghaemmaghami J, Smith M, Ip W, Phillips T, et al.
Blood Adv
. 2023 Jan;
7(15):3952-3967.
PMID: 36630565
Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) play an important role in tumor growth and progression. TAMs have been involved in producing immunosuppressive TME via various factors; however, the...
9.
Gordon M, Smith M, Nastoupil L
Blood Rev
. 2022 Jul;
57:100992.
PMID: 35908982
Follicular lymphoma, the most common indolent lymphoma, though highly responsive to therapy is coupled with multiple relapses for the majority of patients. Advances in biologic understanding of molecular events in...
10.
OBrien-Smith J, Fransen J, Sheehan W, Lenoir M, Bennett K, Smith M
Sci Med Footb
. 2022 Apr;
6(2):164-171.
PMID: 35475747
Background: An expert/non-expert paradigm often helps understand the underpinnings of sports expertise; however, this method is scarcely extended to the complexities of collective behaviour in youth soccer. Aim: Therefore, the...